Sartorius, Sartorius Stedim Biotech jump after Q4 earnings beat

Sartorius AG

28/01/2025 08:06

** Shares in Sartorius  SATG.DE  jump around 10% to May
highs after the German pharmaceutical equipment supplier
reported Q4 earnings beat and strong BPS orders
    ** Q4 underlying EBITDA came in at 259 million, 5% above
beat Vara consensus cited by J.P.Morgan
    ** JPM also cites strong Bioprocess Solutions (BPS) orders
at 856.7 million euros, 22% ahead of the brokerage's estimates
    ** Its French subsidiary Sartorius Stedim Biotech  STDM.PA 
jumps around 12%, with JPM also noting a 3% beat on underlying
EBITDA
    ** Sartorius' stock is among top performers of the German
blue-chip index  .GDAXI , and  both Sartorius and Sartorius
Stedim Biotech are at the top of STOXX 600  .STOXX  index

 (Reporting by Anastasiia Kozlova)
 ((Anastasiia.Kozlova@thomsonreuters.com))